Home › Colorectal Cancer › Texas › Lewisville
Colorectal Cancer clinical trials in Lewisville, TX
3 studies for Colorectal Cancer are looking for participants at sites in and around Lewisville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecruitingPhase 3
- Texas Oncology - Northeast Texas, Flower Mound · 6 mi away
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Texas Oncology - Northeast Texas, Flower Mound · 6 mi away
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RecruitingPhase 2
- Texas Oncology-Grapevine /ID# 275155, Grapevine · 9 mi away
About Colorectal Cancer
Colorectal cancer starts in the colon or rectum. It may not cause symptoms at first. Screening tests can help find it early, when treatment is most effective.
More about Colorectal Cancer on MedlinePlus
Colorectal Cancer trials in other cities
- Houston, TX102 studies
- New York City, NY78 studies
- Nashville, TN69 studies
- Boston, MA63 studies
- Los Angeles, CA59 studies
- Arlington, VA52 studies
- St. Louis, MO50 studies
- San Antonio, TX46 studies
- Philadelphia, PA44 studies
- Grand Rapids, MI40 studies
- Baldwin Park, CA37 studies
- Chicago, IL34 studies
Other studies in Lewisville
- Ulcerative Colitis10 studies
- Crohn's Disease9 studies
- Type 2 Diabetes5 studies
- Breast Cancer5 studies
- Spinal Muscular Atrophy4 studies
- Inflammatory Bowel Disease4 studies
- Digestive Diseases4 studies
- Macular Degeneration3 studies
- Cardiovascular Disease3 studies
- Geographic Atrophy3 studies
- Triple-Negative Breast Cancer3 studies
- Lung Diseases3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.